1.
Kanakaraju VK. Molecular Docking Studies of Schiff Bases with Azetidinone Against Dihydrofolate Reductase Enzyme as Potential Anti-cancer Agents. AJP [Internet]. 2024 Jun. 15 [cited 2025 Jan. 17];18(02). Available from: http://www.asiapharmaceutics.info/index.php/ajp/article/view/5480